ENVM.TA (ENvizion Medical Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

ENVM.TA does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ENVM.TA and 80,000+ other tickers.
See exactly how ENVM.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ENVM.TA and 80,000+ other tickers.
ENvizion Medical Ltd. is a specialized medical device enterprise. Its primary product is the ENvue system, which streamlines the placement of feeding tubes. This innovative system achieves accuracy by integrating navigation capabilities with advanced sensors and detailed body mapping. Founded in 2017, the company maintains its headquarters in Tel Aviv-Yafo, Israel.
No recent news available.